Medications

FDA still skeptical of ALS drug ahead of high-stakes meeting

Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, even as they prepare to give its drugmaker a rare second opportunity ...

Medications

Psychiatrists disagree with US policy on psychoactive drugs

A new national survey reveals considerable differences between psychiatrists' perceptions about the safety and therapeutic value of certain psychoactive drugs and how those same drugs are categorized under U.S. policy.

Health

What Medicare Part A's belly-up date means for you

At its current pace, Medicare's Hospital Insurance trust fund will run out of money in 2028, according to the June 2022 Medicare trustees report. That's a two-year extension on the previous estimate, but experts say it's ...

Medications

How will pending budget bill reduce drug prices for Americans?

The Inflation Reduction Act contains provisions that are expected to lower drug costs for millions of Americans by allowing Medicare to negotiate some drug prices and by limiting the amount of out-of-pocket drug costs for ...

page 13 from 40